Analysis and CYANOTECH CORP (CYAN) Earnings Review

[USA] Wall Street await CYANOTECH CORP (NASDAQ:CYAN) to release earnings on November, 10. The stock closed at $3.7 during the last session. It is down 24.02% since April 7, 2016 and is downtrending. It has underperformed by 28.81% the S&P500.

Insitutional Activity

The institutional sentiment increased to 2 in 2016 Q2. Its up 0.50, from 1.5 in 2016Q1. The ratio increased, as 1 funds sold all CYANOTECH CORP shares owned while 1 reduced positions. 1 funds bought stakes while 3 increased positions. They now own 1.13 million shares or 0.49% more from 1.12 million shares in 2016Q1.
Salem Investment Counselors Inc accumulated 15,178 shares or 0.01% of the stock. Coastline Trust Communication accumulated 82,400 shares or 0.09% of the stock.

The California-based Wells Fargo & Mn has invested 0% in CYANOTECH CORP (NASDAQ:CYAN). Moreover, Royal National Bank Of Canada has 0% invested in CYANOTECH CORP (NASDAQ:CYAN) for 500 shares. Renaissance Technology Ltd Liability Corp holds 96, 300 shares or 0% of its portfolio. California Public Employees Retirement System holds 0% or 19,300 shares in its portfolio. Blackrock Fund Advisors holds 755 shares or 0% of its portfolio. Deutsche State Bank Ag holds 0% or 88 shares in its portfolio. Blackrock Institutional Tru Na has invested 0% of its portfolio in CYANOTECH CORP (NASDAQ:CYAN). Morgan Stanley has 0% invested in the company for 1,500 shares. Vanguard Gp accumulated 0% or 25,563 shares.

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company has a market cap of $19.80 million. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. It currently has negative earnings. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

According to Zacks Investment Research, “CYANOTECH CORP. develops and commercializes natural products from microalgae. Co. is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets and is also developing microalgae-based products for the aquaculture feed/pigments, biopesticide and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients.”

More important recent CYANOTECH CORP (NASDAQ:CYAN) news were published by: Reuters.com which released: “BRIEF-Cyanotech Corp board received letter from Meridian OHC Partners, LP …” on June 08, 2016, also Bizjournals.com published article titled: “Hawaii-based Cyanotech Corp. embroiled in legal case involving shareholder”, Streetinsider.com published: “Meridian OHC Partners Changes Filing Status on Cyanotech Corp (CYAN) from …” on May 09, 2016. More interesting news about CYANOTECH CORP (NASDAQ:CYAN) was released by: Businesswire.com and their article: “Cyanotech® Corporation Earns Non-GMO Project Verification for BULK SCE …” with publication date: September 22, 2016.

 

View original article at: Analysis and CYANOTECH CORP (CYAN) Earnings Review

Algae World News post end logo

 

 

 

 

[interaction id=”57f4563ca2967e643e9765a0″]

 

Leave a Reply